Japan Somnology Center, Neuropsychiatric Research Institute, Shibuya-ku, Tokyo, Japan.
J Clin Sleep Med. 2013 May 15;9(5):461-7. doi: 10.5664/jcsm.2666.
Many patients with panic disorder (PD) experience nocturnal panic attacks. We investigated the differences in demographic variables and symptom characteristics as well as response to treatment among patients with primary day panic (DP), primary nocturnal panic (NP), and the coexistence of DP and NP (DP/NP), and discuss whether NP is a distinct disease category.
One hundred one consecutive untreated patients with PD were enrolled and subsequently divided into the NP, DP, and DP/NP groups. The presence of 13 panic attack symptom items as well as scores on the Panic Disorder Severity Scale (PDSS) and the Pittsburgh Sleep Quality Index (PSQI) were compared among the groups. After 3 months of regular treatment, PDSS scores were assessed again to evaluate treatment response.
Nocturnal panic attacks of the participants were mostly reported to occur in the first tertile of nocturnal sleep. The number of males, onset age, and presence of choking sensation were significantly higher, and the PDSS score was significantly lower in the NP group compared with the other groups. The DP/NP group showed the highest PDSS score, and participants in this group were prescribed the highest doses of medication among all groups. Only diagnostic sub-category was significantly associated with treatment response. The total score for PDSS and PSQI correlated significantly only in the NP group.
DP/NP could be a severe form of PD, while primary NP could be a relatively mild subcategory that may partially share common pathophysiology with adult type night terror.
许多惊恐障碍(PD)患者会经历夜间惊恐发作。我们研究了原发性日间惊恐(DP)、原发性夜间惊恐(NP)以及 DP 和 NP 共存(DP/NP)患者在人口统计学变量和症状特征方面的差异,以及对治疗的反应,探讨 NP 是否为一种独特的疾病类别。
共纳入 101 例未经治疗的 PD 连续患者,随后将其分为 NP、DP 和 DP/NP 组。比较各组中 13 项惊恐发作症状项目的存在情况以及惊恐障碍严重程度量表(PDSS)和匹兹堡睡眠质量指数(PSQI)的评分。经过 3 个月的常规治疗后,再次评估 PDSS 评分以评估治疗反应。
参与者的夜间惊恐发作大多发生在夜间睡眠的前三分位数。NP 组的男性比例、发病年龄和窒息感的出现明显较高,而 PDSS 评分明显较低。DP/NP 组的 PDSS 评分最高,该组患者的药物剂量在所有组中最高。只有诊断亚类与治疗反应显著相关。仅 PDSS 和 PSQI 的总分在 NP 组中存在显著相关性。
DP/NP 可能是 PD 的一种严重形式,而原发性 NP 可能是一种相对较轻的亚类,可能与成人型夜惊部分共享共同的病理生理学机制。